Francisco J Carmona
Overview
Explore the profile of Francisco J Carmona including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borrego-Marin E, Garrido-Barros P, Peterson G, Vismara R, Carmona F, Barea E, et al.
J Am Chem Soc
. 2025 Mar;
PMID: 40064546
The importance of crystal surface reactivity of reticular materials is exemplified by exfoliation of nonporous layered zeolitic imidazolate framework Zn(mIm)·0.5mImH (ZIF-L, mImH = 2-methylimidazole). Sonication of ZIF-L ethanolic suspensions leads...
2.
Jabalera-Ortiz P, Perona C, Moreno-Albarracin M, Carmona F, Jimenez J, Navarro J, et al.
Angew Chem Int Ed Engl
. 2024 Oct;
63(52):e202411867.
PMID: 39400502
Reductive proton-coupled electron transfer (PCET) has important energetic implications in numerous synthetic and natural redox processes. The development of catalytic systems that can mediate such transformations has become an attractive...
3.
Martin-Romera J, Borrego-Marin E, Jabalera-Ortiz P, Carraro F, Falcaro P, Barea E, et al.
ACS Appl Mater Interfaces
. 2024 Feb;
16(8):9900-9907.
PMID: 38344949
Organophosphate (OP) toxicity is related to inhibition of acetylcholinesterase (AChE) activity, which plays a key role in the neurotransmission process. In this work, we report the ability of different zinc...
4.
Carmona F, Negrao Chuba T, Sanchez-Gonzalez E, Pirillo J, Hijikata Y, Furukawa S
J Mater Chem B
. 2023 Dec;
12(1):233-239.
PMID: 38084014
The exogenous administration of nitric oxide (NO) is considered a potential therapeutic treatment against a great variety of diseases due to its significant role in multiple physiological functions. Due to...
5.
Illescas-Lopez S, Martin-Romera J, Manas-Torres M, Lopez-Lopez M, Cuerva J, Gavira J, et al.
ACS Appl Mater Interfaces
. 2023 Jun;
15(27):32597-32609.
PMID: 37390355
The development of bio-MOFs or MOF biocomposites through the combination of MOFs with biopolymers offers the possibility of expanding the potential applications of MOFs, making use of more environmentally benign...
6.
Ortin-Rubio B, Perona-Bermejo C, Suarez Del Pino J, Carmona F, Gandara F, Navarro J, et al.
Chem Commun (Camb)
. 2023 Jun;
59(50):7803-7806.
PMID: 37272083
Metal-organic frameworks (MOFs) based on high-connected nets are generally very attractive due to their combined robustness and porosity. Here, we describe the synthesis of BCN-348, a new high-connected Zr-MOF built...
7.
Gonzalez L, Martin-Romera J, Sanchez-Sanchez P, Navarro J, Barea E, Maldonado C, et al.
Inorg Chem
. 2023 Mar;
62(13):5049-5053.
PMID: 36939843
A novel material with dual activity toward organophosphate (OP) poisoning, based on Zr-MOF-808 and neutral oxime RS69N, has been prepared. The hybrid material has a significant drug payload (5.2 ±...
8.
Carmona F, Guagliardi A, Masciocchi N
Nanomaterials (Basel)
. 2022 Aug;
12(15).
PMID: 35957141
The need for qualitatively and quantitatively enhanced food production, necessary for feeding a progressively increasing World population, requires the adoption of new and sustainable agricultural protocols. Among them, limiting the...
9.
Delgado P, Martin-Romera J, Perona C, Vismara R, Galli S, Maldonado C, et al.
ACS Appl Mater Interfaces
. 2022 Jun;
PMID: 35653699
Organophosphate nerve agents and pesticides are extremely toxic compounds because they result in acetylcholinesterase (AChE) inhibition and concomitant nerve system damage. Herein, we report the synthesis, structural characterization, and proof-of-concept...
10.
Ramirez-Rodriguez G, Dal Sasso G, Carmona F, Miguel-Rojas C, Perez-de-Luque A, Masciocchi N, et al.
ACS Appl Bio Mater
. 2022 Jan;
3(3):1344-1353.
PMID: 35021628
Biomimetic calcium phosphate nanoparticles (CaP) have been actively used in biomedicine, due to their high biodegradability and biocompatibility. However, much less progress has been made regarding their application in precision...